JD Supra14m
European Commission Approves Samsung Bioepis and Biogen’s Aflibercept Biosimilar
On November 18, 2024, Samsung Bioepis announced that the European Commission (EC) has approved its aflibercept biosimilar, OPUVIZ.
JD Supra45m
The EU Commission releases its Fourth Annual FDI report showing continuity and heightened FDI regulation in the EU27
On 17 October, the European Commission (EC) issued its Fourth Annual Report under Article 5(4) of the Foreign Direct Investments (FDI) ...